Literature DB >> 2066656

Probucol prevents oxidative injury to endothelial cells.

M Kuzuya1, M Naito, C Funaki, T Hayashi, K Asai, F Kuzuya.   

Abstract

We evaluated the effect of the antioxidant, probucol, on the cytotoxic effects of oxidized low density lipoprotein (OX-LDL) or of cumene hydroperoxide (CumOOH) on cultured bovine endothelial cells (EC). The addition of CumOOH to EC caused the release of lactate dehydrogenase and the accumulation of thiobarbituric acid-reacting substances (TBARS), effects that were protected against by preincubation with either probucol or tocopherol. Similarly, preincubation of EC with those antioxidants protected against OX-LDL toxicity and the accumulation of TBARS. The content of probucol in EC measured by high performance liquid chromatography was directly correlated with the extent of protection against OX-LDL toxicity. We also found that treatment of EC with serum from patients receiving treatment with probucol resulted in the detection of probucol in the cells. We conclude that probucol is transported and incorporated into EC membranes to act as a radical-trapping antioxidant, protecting the EC against oxidative stress. Our results also indicate that lipid peroxidation in cellular membranes involves cell injury inflicted by OX-LDL.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066656

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  The effect of probucol on the proliferation of cultured human umbilical vascular endothelial cells.

Authors:  T Tajika; Y Ono; K Ono; M Miura; Y Kyo
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

2.  Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative.

Authors:  S Parthasarathy
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

3.  Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.

Authors:  M Naito; K Yamada; T Hayashi; K Asai; N Yoshimine; A Iguchi
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

Review 4.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02

5.  Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

Authors:  Timothy J Lyons; Alicia J Jenkins
Journal:  Diabetes Rev (Alex)       Date:  1997

6.  Chelation of copper reduces inhibition by oxidized lipoproteins of endothelium-dependent relaxation in porcine coronary arteries.

Authors:  T Hayashi; T Ishikawa; M Kuzuya; M Naito; K Yamada; K Asai; H Hidaka; A Iguchi
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

7.  In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals.

Authors:  M D Coffey; R A Cole; S M Colles; G M Chisolm
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

8.  Probucol attenuates hyperoxia-induced lung injury in mice.

Authors:  Tomonobu Kawaguchi; Toyoshi Yanagihara; Tetsuya Yokoyama; Saiko Suetsugu-Ogata; Naoki Hamada; Chika Harada-Ikeda; Kunihiro Suzuki; Takashige Maeyama; Kazuyoshi Kuwano; Yoichi Nakanishi
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

9.  Enhanced Antioxidant Effects of the Anti-Inflammatory Compound Probucol When Released from Mesoporous Silica Particles.

Authors:  Michael Lau; Benjamin Sealy; Valery Combes; Marco Morsch; Alfonso E Garcia-Bennett
Journal:  Pharmaceutics       Date:  2022-02-24       Impact factor: 6.525

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.